Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Status:
Completed
Trial end date:
2014-05-28
Target enrollment:
Participant gender:
Summary
Subjects referred for a routine CTA (computed tomography angiography) or MRA (magnetic
resonance angiography) will be invited to participate in the study and subjects will be
involved in the study for between 2 and 12 days. Two to three visits to the study doctor will
be required.
This study will compare the diagnostic results of Gadobutrol enhanced MRA images with MRA
images taken without contrast agent using images from a CTA as the standard of reference,
which may have been performed up to 60 days prior to enrolment. If a CTA has not been
performed in this prior time period, a CTA is required for the study.
MRA and CTA images will be collected for an independent review (blinded read).